Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

PH — Parker Hannifin

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 21.53%
Profit Margins 16.58%
Return on Equity 24.84%
Return on Assets 9.54%
Free Float 0.13B
Dividend Yield 0.83%
Short Int % Utilisation 1.27%

2.2 Growth

Metric Value
Revenue Growth 10.6%
Free Cash Flow 2.77B
EBITDA 21.81 (Ratio)
Enterprise Value 119.52B
EV/Revenue 5.7
EV/EBITDA 21.81

Revenue growth of 10.6% indicates steady, moderate expansion.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 51.29%
Risk / Std Dev (Ann.)* 25.97%
1-Year Price Return* 45.90%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $1,055.85
52-Week Range $715.37 – $1,099.94
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $19.85B $19.93B
Net income Reported net income $3.53B $2.84B
Total assets Year-end reported balance $29.49B $29.30B
Shareholders’ equity Year-end reported balance $13.68B $12.07B
Net margin Net income ÷ revenue 17.79% 14.27%
Asset turnover Revenue ÷ total assets 0.6730x 0.6803x
Equity multiplier Total assets ÷ shareholders’ equity 2.1557x 2.4269x
ROE Net margin × asset turnover × equity multiplier 25.81% 23.56%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $19.85B
Prior annual revenue $19.93B
EBIT $4.52B
Tax rate 14.00%
NOPAT = EBIT × (1 − tax rate) $3.88B
Forecast start-growth basis -0.40%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $3.88B
Add: depreciation & amortisation $907.00M
Less: capital expenditure -$435.00M
Less/(add): working-capital cash-flow movement -$305.00M
Current unlevered FCFF $4.05B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 -0.40% $3.87B $903.36M -$433.25M -$303.78M $4.03B $3.84B
2 0.32% $3.88B $906.29M -$552.56M -$304.76M $3.93B $3.39B
3 1.05% $3.92B $915.80M -$677.51M -$307.96M $3.85B $3.01B
4 1.77% $3.99B $932.05M -$810.79M -$313.42M $3.80B $2.68B
5 2.50% $4.09B $955.35M -$955.35M -$321.26M $3.77B $2.41B

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 1.13
Cost of equity 10.92%
Pre-tax cost of debt 4.12%
WACC 10.43%
WACC validation within standard range

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $48.74B
Implied terminal EV / EBITDA 8.53x
Terminal value as % of enterprise value 65.95%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $15.33B
Present value of terminal value $29.68B
Indicated enterprise value $45.01B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $45.01B
Less: gross interest-bearing debt $9.29B
Add: cash and equivalents $467.00M
Add: affiliate investments $0.00
Less: minority interests $9.00M
Indicated common equity value $36.18B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 130,200,000.00
Share-count basis reported diluted weighted-average shares
Current market price $1,037.04
DCF indicative value per share $277.91
Indicative value vs. market price -73.20%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range pass
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 3/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:45:42.698255 UTC; latest reported fiscal period: 2025-06-30 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha 1.44% 8.77%
Adjusted R² 0.29 0.30
Annualised residual volatility 21.53% 21.26%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 1.02 (8.06) 1.18 (8.17)
Size (SMB) 0.16 (0.91) 0.12 (0.64)
Value (HML) 0.77 (5.24) 0.56 (3.12)
Profitability (RMW) NM 0.21 (1.38)
Investment (CMA) NM 0.41 (1.55)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequityphindustrialsindustrial-machinery--supplies--componentsnasdaq